{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:20:08Z","timestamp":1762942808537,"version":"3.45.0"},"reference-count":22,"publisher":"BMJ","issue":"23","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,4,6]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Upper gastrointestinal (GI) bleeding following transcatheter aortic valve replacement (TAVR) is common in patients with aortic stenosis due to the combination of acquired type 2A von Willebrand disease and aspirin-based antiplatelet therapy. We aimed to investigate the incidence, predictors and clinical outcomes of late upper GI bleeding in patients undergoing TAVR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prospective TAVR registry, patients were stratified according to upper GI bleeding within 1 year of discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 3144 eligible patients, 54 (1.7%) experienced upper GI bleeding after discharge. Of these, 40 patients had major or life-threatening bleeding, while 14 had minor bleeding events. The presence of atrial fibrillation or atrial flutter (HR\n                      <jats:sub>adjusted<\/jats:sub>\n                      2.98; 95%\u2009CI 1.65 to 5.38) and previous upper GI bleeding (HR\n                      <jats:sub>adjusted<\/jats:sub>\n                      3.51; 95%\u2009CI 1.51 to 8.19) were independent predictors of upper GI bleeding, while the use of proton pump inhibitors at discharge (HR\n                      <jats:sub>adjusted<\/jats:sub>\n                      0.49; 95%\u2009CI 0.27 to 0.89) and higher haemoglobin levels (1\u2009g\/dL increase) (HR\n                      <jats:sub>adjusted<\/jats:sub>\n                      0.73; 95%\u2009CI 0.62 to 0.87) were protective. Patients who experienced major or life-threatening upper GI bleeding had a higher all-cause (73.7% vs 11.4%, HR 5.84; 95%\u2009CI 3.41 to 10.02) and cardiovascular mortality (31.6% vs 7.3%, HR 3.87; 95%\u2009CI 1.72 to 8.70) compared with those without upper GI bleeding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients who underwent TAVR, 1.7% of patients experienced upper GI bleeding within 1 year of discharge. Major or life-threatening upper GI bleeding was associated with an increased risk of all-cause and cardiovascular mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01368250\">NCT01368250<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2024-325359","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T13:20:24Z","timestamp":1746883224000},"page":"1149-1155","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement"],"prefix":"10.1136","volume":"111","clinical-trial-number":[{"clinical-trial-number":"nct01368250","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01368250","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01368250","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-8494","authenticated-orcid":false,"given":"Masaaki","family":"Nakase","sequence":"first","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik F","family":"Draxler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-1335","authenticated-orcid":false,"given":"Daijiro","family":"Tomii","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dik","family":"Heg","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-2934","authenticated-orcid":false,"given":"Taishi","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daryoush","family":"Samim","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Lanz","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Stortecky","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Reineke","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pilgrim","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"2025111202150560000_111.23.1149.1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","article-title":"Bleeding Events After Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review","volume":"81","author":"Avvedimento","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025111202150560000_111.23.1149.2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008227","article-title":"Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapies Registry","volume":"13","author":"Sherwood","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"2025111202150560000_111.23.1149.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.08.052"},{"key":"2025111202150560000_111.23.1149.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.04.034"},{"key":"2025111202150560000_111.23.1149.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404"},{"key":"2025111202150560000_111.23.1149.6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ehjqcco\/qcy048","article-title":"Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis","volume":"5","author":"Stortecky","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025111202150560000_111.23.1149.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.001"},{"key":"2025111202150560000_111.23.1149.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.12.005"},{"key":"2025111202150560000_111.23.1149.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.038"},{"key":"2025111202150560000_111.23.1149.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac105"},{"key":"2025111202150560000_111.23.1149.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2023.10.011"},{"key":"2025111202150560000_111.23.1149.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1205363"},{"key":"2025111202150560000_111.23.1149.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.041"},{"key":"2025111202150560000_111.23.1149.14","doi-asserted-by":"crossref","first-page":"18020","DOI":"10.1038\/nrdp.2018.20","article-title":"Non-variceal upper gastrointestinal bleeding","volume":"4","author":"Lanas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025111202150560000_111.23.1149.15","first-page":"E53","article-title":"Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis","volume":"90","author":"Stanger","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025111202150560000_111.23.1149.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067312"},{"key":"2025111202150560000_111.23.1149.17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012812","article-title":"Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives","volume":"16","author":"Mesnier","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"2025111202150560000_111.23.1149.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.02.008"},{"key":"2025111202150560000_111.23.1149.19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.011848","article-title":"Reduction of Gastrointestinal Bleeding in Patients With Heyde Syndrome Undergoing Transcatheter Aortic Valve Implantation","volume":"15","author":"Goltstein","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"2025111202150560000_111.23.1149.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042087"},{"key":"2025111202150560000_111.23.1149.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007964"},{"key":"2025111202150560000_111.23.1149.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.10.010"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2024-325359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:15:21Z","timestamp":1762942521000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2024-325359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":22,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,11,12]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/heartjnl-2024-325359"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2024-325359","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2025,5,10]]}}}